|
CN105218476A
|
|
A kind of preparation method treating lung-cancer medicament
|
|
CN104311453A
|
|
Preparation method of anti-hypertensive drug
|
|
CN105315212A
|
|
Preparation method for vasopressin antagonist
|
|
CN105315169A
|
|
Preparation method for cardiovascular disease treatment drug
|
|
CN104119424A
|
|
Method for preparing (4S)-3-[(2S)-2[(1S)-1-ethoxycarbonyl-3-phenylpropyl] amino-propionyl]-1-methyl-2-oxo-imidazole-4-carboxylic acid
|
|
CN104119344A
|
|
Novel method for preparing 6,7-dichloro-1,5-imidazolinyl [2,1-b] quinazoline-2-(3H)-one
|
|
CN104119279A
|
|
Novel method for preparing 2-ethyoxyl-1-{[2'-(5-carbonyl-4,5-dihydro-1,2,4-oxadiazole-3-yl) xenyl-4-yl]methyl}-1H- benzimidazole-7-carboxylic acid
|
|
CN104119273A
|
|
Novel method for preparing dextromethorphan
|
|
CN104557573A
|
|
Preparation method of (1S)-4,5-dimethoxy-1-[(methylamino)methyl]benzocyclobutane hydrochloride
|
|
CN104447685A
|
|
Preparation method of alogliptin
|
|
CN104418803A
|
|
Preparation method of tolvaptan
|
|
CN104370850A
|
|
Ziprasidone key intermediate preparation method
|
|
CN103570726A
|
|
N-alkyl tryptanthrin derivative, as well as preparation method and application thereof
|
|
CN103570671A
|
|
Efficient blood glucose reducing compound as well as preparation and application thereof
|
